The Readout Loud

View Top 200 Chart

Back to Rankings Page

Business
**The Readout Loud**

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Latest Episodes:

Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue Sep 05, 2019

Show notes

What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?

Episode 77: Purdue, J&J, and a week of big opioid crisis news Aug 29, 2019

Show notes

What does Dr. Richard Sackler sound like? When is $500 million a small amount of money? And what will come of the drug companies at the heart of the opioid crisis?

Episode 76: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech Aug 22, 2019

Show notes

How should you talk to friends about rejection? Can Facebook actually improve the lives of children? And how's biotech doing in China?

Episode 75: The serious side of spit kits, how BiTEs leave a mark, & Sarepta's sluggish study Aug 15, 2019

Show notes

Is anything too weighty to be explained over the internet? Can a new spin on old technology outfox CAR-T? And does that controversial drug even work?

Episode 74: Novartis and the no good, very bad week Aug 08, 2019

Show notes

Why did Novartis (NVS) keep its scandal to itself? Who knew what and when? And is there such thing as too much Peloton time?

Episode 73: Canadian pills, corporate jets, & racists with spit kits Aug 01, 2019

Show notes

Will Canada run out of drugs? Should you ever read your partner's diary? And what does Pepe the Frog know about genomics?

Episode 72: Vertex's regime change, the return of Ebola, & the rise of digital health Jul 25, 2019

Show notes

What makes an epidemic newsworthy? Can biotech succession succeed? And what's so novel about digital health?

Episode 71: Elon Musk's monkey cyborg, Gilead's shifting future, & an app for anxiety Jul 18, 2019

Show notes

Can apps treat anxiety? Is Gilead Sciences back on track? And are we all just brains in a vat?

Episode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech Jul 11, 2019

Show notes

Is drug pricing too complex for the Trump administration? Would you recognize Tom Hanks at a party? And what does it mean when famous executives quit?

Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing Jun 27, 2019

Show notes

Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected